Kiora Pharmaceuticals (KPRX) Invested Capital (2016 - 2023)
Kiora Pharmaceuticals' (KPRX) quarterly Invested Capital came in at $495000.0 in Q3 2023, up 57.79% YoY from $313714.0 in Q3 2022, and up 57.72% on a QoQ basis from $313853.0 in Q2 2023.
Kiora Pharmaceuticals (KPRX) Invested Capital (2016 - 2023) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 3 years of Invested Capital data on file, last reported at $495000.0 in Q3 2023.
- Quarterly Invested Capital rose 57.79% year-over-year to $495000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $495000.0 (down 60.82% YoY) and the FY2022 annual result came in at $322385.0, changed N/A from the prior year.
- Invested Capital advanced to $495000.0 in Q3 2023, from $313853.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $495000.0 in Q3 2023 to a low of $293947.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 495,000.00 |
| Jun 30, 2023 | 313,853.00 |
| Mar 31, 2023 | 313,299.00 |
| Dec 31, 2022 | 322,385.00 |
| Sep 30, 2022 | 313,714.00 |
| Jun 30, 2022 | 301,808.00 |
| Mar 31, 2022 | 293,947.00 |
| Mar 31, 2016 | 1.21 Mn |